News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
849,275 Results
Type
Article (76924)
Company Profile (717)
Press Release (771604)
Multimedia
Podcasts (212)
Webinars (34)
Section
Business (228622)
Career Advice (3761)
Deals (39586)
Drug Delivery (168)
Drug Development (90044)
Employer Resources (207)
FDA (18259)
Job Trends (17272)
News (390357)
Policy (39124)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (3041)
Academic (1)
Accelerated approval (46)
Adcomms (37)
Allergies (178)
Alliances (56217)
ALS (209)
Alzheimer's disease (1899)
Antibody-drug conjugate (ADC) (443)
Approvals (18512)
Artificial intelligence (709)
Autoimmune disease (262)
Automation (55)
Bankruptcy (405)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (225)
Biotechnology (443)
Bladder cancer (187)
Brain cancer (76)
Breast cancer (737)
Cancer (5779)
Cardiovascular disease (512)
Career advice (3232)
Career pathing (48)
CAR-T (336)
CDC (72)
Celiac Disease (2)
Cell therapy (907)
Cervical cancer (45)
Clinical research (76868)
Collaboration (2164)
Company closure (6)
Compensation (1345)
Complete response letters (96)
COVID-19 (3018)
CRISPR (112)
C-suite (1107)
Cystic fibrosis (161)
Data (7410)
Decentralized trials (3)
Denatured (78)
Depression (178)
Dermatology (71)
Diabetes (596)
Diagnostics (7431)
Digital health (56)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (346)
Drug pricing (238)
Drug shortages (39)
Duchenne muscular dystrophy (288)
Earnings (98800)
Editorial (72)
Employer branding (25)
Employer resources (174)
Events (135657)
Executive appointments (1129)
FDA (21919)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1770)
Gene editing (241)
Generative AI (73)
Gene therapy (752)
GLP-1 (1217)
Government (5478)
Grass and pollen (8)
Guidances (404)
Healthcare (21038)
HIV (83)
Huntington's disease (58)
IgA nephropathy (98)
Immunology and inflammation (332)
Immuno-oncology (97)
Indications (164)
Infectious disease (3376)
Inflammatory bowel disease (224)
Inflation Reduction Act (17)
Influenza (142)
Intellectual property (286)
Interviews (733)
IPO (17911)
IRA (61)
Job creations (5016)
Job search strategy (2610)
JPM (73)
Kidney cancer (19)
Labor market (107)
Layoffs (667)
Leadership (46)
Legal (9989)
Liver cancer (106)
Longevity (30)
Lung cancer (771)
Lymphoma (422)
Machine learning (56)
Management (66)
Manufacturing (1042)
MASH (196)
Medical device (15148)
Medtech (15236)
Mergers & acquisitions (22867)
Metabolic disorders (1611)
mRNA (221)
Multiple sclerosis (186)
NASH (24)
Neurodegenerative disease (440)
Neuropsychiatric disorders (117)
Neuroscience (3455)
Neurotech (1)
NextGen: Class of 2026 (7665)
Non-profit (5129)
Now hiring (75)
Obesity (790)
Opinion (360)
Ovarian cancer (201)
Pain (256)
Pancreatic cancer (279)
Parkinson's disease (373)
Partnered (36)
Patents (590)
Patient recruitment (647)
Peanut (65)
People (66377)
Pharmaceutical (128)
Pharmacy benefit managers (36)
Phase 1 (23764)
Phase 2 (33505)
Phase 3 (25244)
Pipeline (7651)
Policy (376)
Postmarket research (3286)
Preclinical (10459)
Press Release (72)
Prostate cancer (294)
Psychedelics (61)
Radiopharmaceuticals (339)
Rare diseases (1130)
Real estate (7220)
Recruiting (81)
Regulatory (29114)
Reports (73)
Research institute (2753)
Resumes & cover letters (586)
Rett syndrome (34)
RNA editing (24)
RSV (97)
Schizophrenia (182)
Series A (297)
Series B (219)
Service/supplier (26)
Sickle cell disease (115)
Special edition (30)
Spinal muscular atrophy (185)
Sponsored (52)
Startups (4262)
State (2)
Stomach cancer (21)
Supply chain (137)
Tariffs (104)
The Weekly (131)
Vaccines (1238)
Venture capital (112)
Weight loss (542)
Women's health (118)
Worklife (24)
Date
Today (158)
Last 7 days (629)
Last 30 days (2789)
Last 365 days (32417)
2026 (9672)
2025 (32544)
2024 (37888)
2023 (42566)
2022 (53927)
2021 (58723)
2020 (57663)
2019 (51307)
2018 (39091)
2017 (36859)
2016 (37777)
2015 (43769)
2014 (38490)
2013 (34493)
2012 (36409)
2011 (36519)
2010 (35991)
Location
Africa (1219)
Alabama (100)
Alaska (7)
Arizona (352)
Arkansas (16)
Asia (50564)
Australia (8707)
California (12975)
Canada (3668)
China (1364)
Colorado (562)
Connecticut (570)
Delaware (391)
Europe (114899)
Florida (1942)
Georgia (425)
Hawaii (4)
Idaho (68)
Illinois (1092)
India (92)
Indiana (611)
Iowa (24)
Japan (523)
Kansas (137)
Kentucky (52)
Louisiana (44)
Maine (87)
Maryland (1596)
Massachusetts (9493)
Michigan (384)
Minnesota (736)
Mississippi (7)
Missouri (158)
Montana (37)
Nebraska (30)
Nevada (144)
New Hampshire (90)
New Jersey (3496)
New Mexico (33)
New York (3438)
North Carolina (1765)
North Dakota (10)
Northern California (6349)
Ohio (401)
Oklahoma (26)
Oregon (53)
Pennsylvania (2593)
Puerto Rico (29)
Rhode Island (53)
South America (1585)
South Carolina (84)
South Dakota (2)
Southern California (5066)
Tennessee (207)
Texas (2080)
United States (46633)
Utah (392)
Vermont (1)
Virginia (329)
Washington D.C. (88)
Washington State (1072)
West Virginia (4)
Wisconsin (144)
Wyoming (2)
849,275 Results for "harbin pharmaceutical group holding co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company - March 12, 2026
March 13, 2026
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company
December 5, 2025
·
3 min read
Press Releases
Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound
January 12, 2026
·
5 min read
Press Releases
Juvisé Pharmaceuticals Formally Approved the Appointments of Frédéric Mascha as Executive Chairman and Chairman of the Supervisory Committee and the Nomination of Renaud Sermondade as the Group’s New CEO
April 16, 2026
·
2 min read
Press Releases
Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd
November 6, 2025
·
3 min read
Press Releases
Taiwan-Based Towards Buddha Co., Ltd. Showcases Medical-Grade TPU Tubing Injection Solutions at Medtec Japan 2026
April 9, 2026
·
2 min read
Press Releases
Aligos Therapeutics Enters into Exclusive License Deal with Xiamen Amoytop Biotech Co., Ltd. to Develop and Commercialize Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
April 16, 2026
·
8 min read
Press Releases
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
January 19, 2026
·
4 min read
Earnings
Novo Holdings’ Assets Fell 34% in 2025 As Its Namesake Drugmaker Struggled
Total assets under management for Novo Holdings, Novo Nordisk’s controlling shareholder, fell by more than one-third last year. The report caps off a tumultuous year for the Novo group of companies.
March 12, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Notice of Faron Pharmaceuticals LTD’s Annual General Meeting
April 10, 2026
·
17 min read
1 of 84,928
Next
